Cargando…
Current status of stereotactic ablative body radiotherapy in the UK: six years of progress
OBJECTIVE: To update the 2012 UK stereotacticablative radiotherapy (SABR) Consortium survey and assess the development of SABR services across the UK over the past 6 years. Use the results to share practice and continue to drive forward technique development, aid standardization and by highlighting...
Autores principales: | Distefano, Gail, Garikipati, Satya, Grimes, Helen, Hatton, Matthew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The British Institute of Radiology.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7592489/ https://www.ncbi.nlm.nih.gov/pubmed/33178949 http://dx.doi.org/10.1259/bjro.20190022 |
Ejemplares similares
-
Current status of stereotactic body radiotherapy for the treatment of hepatocellular carcinoma
por: Park, Jongmoo, et al.
Publicado: (2019) -
Cardiac stereotactic ablative radiotherapy for control of refractory ventricular tachycardia: initial UK multicentre experience
por: Lee, Justin, et al.
Publicado: (2021) -
Stereotactic ablative body radiotherapy in patients with prostate cancer
por: Loblaw, Andrew, et al.
Publicado: (2018) -
Evolution of Stereotactic Ablative Radiotherapy in Lung Cancer and Birmingham’s (UK) Experience
por: Yahya, Sundus, et al.
Publicado: (2018) -
First UK patient cohort treated with stereotactic ablative radiotherapy for primary kidney cancer
por: Zarkar, Anjali, et al.
Publicado: (2023)